Načítá se...
USE OF A NOVEL PRESCRIBING APPROACH FOR THE TREATMENT OF OPIOID USE DISORDER: BUPRENORPHINE/NALOXONE MICRO-DOSING – A CASE SERIES
INTRODUCTION AND AIMS. Buprenorphine/naloxone is an evidence-based treatment for opioid use disorder, but an identified limitation is the period of required opioid abstinence prior to induction on the medication. ‘Micro-dosing’, or using incrementally increasing doses of buprenorphine/naloxone over...
Uloženo v:
| Vydáno v: | Drug Alcohol Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7919736/ https://ncbi.nlm.nih.gov/pubmed/32657496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dar.13113 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|